UCSF to Host Scientific Symposium on Pandemic Flu on Dec. 12

By Jeff Norris

The UCSF Department of Epidemiology and Biostatistics will present a scientific symposium on the pandemic flu threat, to take place in UCSF School of Nursing, room N 225 on the Parnassus campus, from 1 to 5 p.m. on Monday, Dec. 12. Scientific experts from UCSF, the UC Berkeley School of Public Health, the UC Davis School of Veterinary Medicine, the California Department of Health Services and the biotech industry will participate. Influenza pandemics - such as the 1968 "Hong Kong" flu and the great 1918-1919 "Spanish" flu epidemic that killed perhaps 40 million globally -- seem to arise and travel around the world every two to three decades. A new avian influenza virus, H5N1, has emerged and recently become widespread in Southeast Asia and China. It has caused dozens of deaths via bird-to-human transmission. It is regarded as the latest candidate for possible evolution into a more infectious, still deadly pathogen that could be transmitted directly from human to human. Human populations have not been exposed to this subtype of flu virus before and would not have acquired immunity from previous exposure to related influenza strains or seasonal flu shots. This lack of prior exposure, if coupled with high human-to-human transmissibility, would increase the risk of pandemic spread. Driven by the perceived risk posed by a possibly rapid evolution of the H5N1 virus, policymakers in the US and worldwide now are beginning to plan a response to the threat of pandemic influenza. Symposium speakers will discuss pandemic influenza prevention and control, the biology of flu viruses, the current avian flu threat, and lessons learned from the 1918-1919 influenza pandemic and the 1976 Swine flu. Symposium Program Schedule: 1-1:05 Welcome and Overview of Symposium
  • George Rutherford, M.D., Salvatore Pablo Lucia Professor of Epidemiology and Preventive Medicine, Chief, Division of Preventive Medicine and Public Health, Department of Epidemiology and Biostatistics

1:05-1:35 Session 1: Biology of influenza viruses

  • 1:05-1:20 Virology of influenza viruses with emphasis on 1918-19 strain and A/H5N1 (includes discussion of efforts to recreate 1918-19 strain) - Raul Andino-Pavlovsky, Ph.D., Professor of Microbiology and Immunology
  • 1:20-1:35 Historical epidemiology and epizoology of influenza viruses - Rutherford
1:35-2:30 Session II: The 1918-1919 influenza pandemic
  • 1:35-1:55 What happened in 1918-1919 - John Lesch, Ph.D., Professor of History, University of California, Berkeley
  • 1:55-2:05 Theories of differential mortality in the 1918-1919 pandemic - Andrew Noymer, Ph.D. (cand.), Department of Sociology, UCB
  • 2:05-2:15 Clinical manifestations - Peggy Weintrub, M.D., Professor of Clinical Pediatrics
  • 2:15-2:30 Questions and answers
2:30-2:45 Break 2:45-3:40 Session III: Influenza A/H5NI
  • 2:45-3:00 Recent epidemiology and epizoology - Janice Louie, M.D., M.P.H., Assistant Chief, Viral and Rickettsial Diseases Laboratory, California Department of Health Services, and Assistant Clinical Professor of Medicine
  • 3:00-3:15 Clinical manifestations in poultry and fowl - Carol Cardona, D.V.M., Ph.D., Associate Extension Specialist, Department of Population Health and Reproduction, Veterinary Extension, School of Veterinary Medicine, University of California, Davis
  • 3:15-3:30 Clinical manifestations in humans and diagnostic issues - Lawrence Drew, M.D., Ph.D., Professor of Laboratory Medicine
3:40-5:20 Session IV: Pandemic influenza prevention and control
  • 3:40-3:50 Mortality estimates and modeling - Travis Porco, Ph.D., Lecturer, Center for Infectious Disease Preparedness, School of Public Health, University of California, Berkeley
  • 3:50-4:05 Antivirals - mechanisms of action, toxicity, resistance, susceptibility and manufacturing issues -B. Joseph Guglielmo, Pharm.D., Professor of Clinical Pharmacy
  • 4:05-4:20 Vaccine manufacturing issues - Peter Dull, M.D., M.S., Chiron Corporation
  • 4:20-4:30 Hospital preparedness and infection control - Amy Nichols, R.N., M.B.A., C.I.C., Director, Infection Control, UCSF Medical Center (10 minutes)
  • 4:30-4:40 UCSF preparedness - Peter Jensen, M.D., Clinical Professor of Medicine, Chief of Infectious Diseases, Veterans Affairs Medical Center
  • 4:40-5:00 National and statewide preparedness - Howard Backer, M.D., M.P.H., Chief, Immunizations Branch, California Department of Health Services
  • 5:00-5:20 Questions and answers
  • 5:20 Closing remarks
For more information about the Dec. 12 symposium, please contact Tara Horvath, UCSF Institute for Global Health. Source: Jeff Norris Links: UCSF Institute for Global Health